Research  >  Areas of focus  >  Research Programs  >  Odette Cancer Research  >  Scientists
Share:  
|
PAGE
MENU

Scientist profiles A-F

Photo of Julie Hallet
Julie Hallet, MD, M.Sc., FRCSC

Associate scientist

Sunnybrook Health Sciences Centre
2075 Bayview Ave., Room T2 63
Toronto, ON
M4N 3M5

Phone: 416-480-6100, ext. 4774
Fax: 416-480-6002

Administrative Assistant: Cyril Manahan
Phone: 416-480-4774
Email: cyril.manahan@sunnybrook.ca

Education:

  • MD, 2006, Université Laval, Canada
  • Specialty training, 2011, general surgery, Université Laval, Canada
  • M.Sc., clinical epidemiology, Université Laval, Canada
  • Fellowship training, 2014, surgical oncology, University of Toronto, Canada
  • Advanced training, 2014, minimally invasive surgery, Institute of Research Against Digestive Cancer, Institute of Image-Guided Minimally Invasive Surgery, Institut Hospitalier Universitaire de Strasbourg, France

Appointments and Affiliations:

Research Foci:

  • Health services outcomes-based research
  • Processes of care and outcomes in neuroendocrine tumours
  • Surgical outcomes for hepato-pancreato-biliary cancers
  • Clinical application of minimally invasive therapies in hepato-pancreato-biliary surgery
  • Pre-operative simulation, virtual planning and intra-operative navigation in liver surgery 

Research Summary:

The focus of Dr. Hallet’s research is on conducting health services population-based research to examine processes, patterns of care and outcomes hepato-pancreato-biliary malignancies.

In particular, Dr. Hallet is dedicated to improving care and outcomes of neuroendocrine tumours by identifying and establishing enablers to timely diagnosis and effective management.

She is also working on implementing and evaluating outcomes of pre-operative 3-D planning and intra-operative navigation programs for liver surgery.

Selected Publications:

See current publications list at PubMed.

  1. Hallet J, Law CHL, Cheung M, Mittmann N, Liu N, Fischer HD, Singh S. Patterns and drivers of costs for neuroendocrine tumor care: a comparative population-based analysis. Ann Surg Oncol. 2017. doi: 10.1245/s10434-017-5986-0. Epub ahead of print.
  2. Hallet J, Sa Cunha A, Adam R, Goéré D, Bachelier P, Azoulay D, Ayav A, Grégoire E, Navarro F, Pessaux P; French Colorectal Liver Metastases Working Group, Association Française de Chirurgie (AFC). Br J Surg. 2016;103(10):1366-76.
  3. Hallet J, Law CH, Karanicolas PJ, Saskin R, Liu N, Singh S. Rural-urban disparities in incidence and outcomes of neuroendocrine tumors: A population-based analysis of 6271 cases. Cancer. Epub 2015 Mar 30. doi: 10.1002/cncr.29338.
  4. Hallet J, Law C, Cukier M, Saskin R, Liu N, Singh S. Exploring rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation and outcomes. Cancer. 2015 Feb 15;121(4):589–97.
  5. Hallet J, Tsang ME, Cheng ES, Habashi R, Kulyk I, Hanna SS, Coburn NG, Lin Y, Law CH, Karanicolas PJ. The impact of perioperative red blood cell transfusions on long-term outcomes after hepatectomy for colorectal liver metastases. Ann Surg Oncol. 2015 Nov;22(12):4038–45.

Related News and Stories: